DMD and brain neoplasm: The two activated UPRs specific to GL261(scid) tumor responses have glial cell-related functions: DMD may relate to glial cell differentiation [62]; and SPARC can inhibit brain tumor cell growth but also promotes invasion by increasing binding of extracellular matrix proteins [34–36].